TechEmpower
DECEMBER 11, 2023
Given this diversity, it's important to be selective in the development services company with whom you choose to partner. In the 25 years that TechEmpower has been in business, we’ve seen thousands of companies come and go. This article will primarily focus on locating and evaluating development companies, rather than design firms.
Berkonomics
MAY 9, 2024
Conversely, a fast-growing industry lifts most all good participants, making excellent companies excel even more and grow even faster, like a small plane flying at 150 knots with a 75-knot tailwind. Some great ideas just cannot be made into a product at a reasonable enough price to attract customers. How large is your total market?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Xconomy
APRIL 9, 2019
Executives from five of the companies that negotiate drug prices on behalf of insurers testified Tuesday before the Senate finance committee. These companies, known as pharmacy benefit managers (PBMs), negotiate prices with drug companies, using access as leverage.
Xconomy
FEBRUARY 1, 2019
Pharmaceutical companies typically raise prescription drug prices at the start of each year and this year was no different. The increases were the latest reminder that, despite President Trump’s fiery campaign rhetoric, the administration had done little to actually lower drug prices.
Both Sides of the Table
SEPTEMBER 28, 2014
I was reading Danielle Morrill’s blog post today on whether one’s “ Startup Burn Rate is Normal. But what IS the right amount of burn for a company? Burn rate in case you don’t know is the amount of money a company is either spending (gross) or losing (net) per month. (it Let’s set up a framework.
Both Sides of the Table
SEPTEMBER 15, 2022
<== Our conclusion was that this isn’t a temporary blip that will swiftly trend-back up in a V-shaped recovery of valuations but rather represented a new normal on how the market will price these companies somewhat permanently. We’ll just wait until companies that last raised in 2019 or 2020 come to market.” It’s just math.
Xconomy
FEBRUARY 26, 2019
Seven top pharmaceutical executives gathered today in Washington, DC, for a Senate hearing on drug prices, bringing face-to-face two groups held in the lowest esteem possible by the American public. By the end of the highly anticipated grilling before the Senate’s finance committee, their strategy for taking on two major.
Expert insights. Personalized for you.
295 
Let's personalize your content